Survival benefit from adjuvant TACE combined with lenvatinib for patients with hepatocellular carcinoma and microvascular invasion after curative hepatectomy

Survival benefit from adjuvant TACE combined with lenvatinib for patients with hepatocellular carcinoma and microvascular invasion after curative hepatectomy

Background and aims: The prognosis of patients with hepatocellular carcinoma (HCC) undergoing hepatectomy is unsatisfactory, especially for those with microvascular invasion (MVI). This study aimed to determine the impact of adjuvant transcatheter arterial chemoembolization (TACE) and Lenvatinib on...

Full description

Saved in:
Bibliographic Details
Main Authors: Lei Liang, Zhu-Ding Xu, Wen-Feng Lu, Cheng-Fei Du, Zhen-Yu Gao, Xiao-Kun Huang, Kai-Di Wang, Tai-Wei Ye, Mu-Gen Dai, Si-Yu Liu, Guo-Liang Shen, Jun-Wei Liu, Cheng-Wu Zhang, Dong-Sheng Huang
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Asian Journal of Surgery
Subjects:
Hepatocellular carcinoma
Microvascular invasion
Transcatheter arterial chemoembolization
Lenvatinib
Hepatectomy
Online Access:http://www.sciencedirect.com/science/article/pii/S101595842400839X
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S101595842400839X

Similar Items